Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jinquan Luo

Showing results (31-40 of 48) with videos related to

Pageof 5
Sort By:
Scientific Reports|January 28, 2024
Molecular determinants of ASIC1 modulation by divalent cationsYi Liu, Jichun Ma, Renee L DesJarlais, et al.
Proteins|January 23, 2016
Epitope mapping and structural basis for the recognition of phosphorylated tau by the anti-tau antibody AT8Thomas J Malia, Alexey Teplyakov, Robin Ernst, et al.
Communications Biology|February 10, 2021
Molecular mechanism and structural basis of small-molecule modulation of the gating of acid-sensing ion channel 1Yi Liu, Jichun Ma, Renee L DesJarlais, et al.
Mabs|December 12, 2025
Fine-tuning affinity and spacer design enhances T cell potency in DLL3 and BCMA CAR T cellsNicholas Mazzanti, Ninkka Tamot, Andrea Francese, et al.
Proteins|September 22, 2009
Structure of the EMMPRIN N-terminal domain 1: dimerization via beta-strand swappingJinquan Luo, Alexey Teplyakov, Galina Obmolova, et al.
The Biochemical Journal|December 8, 2004
A novel site contributing to growth-arrest-specific gene 6 binding to its receptors as revealed by a human monoclonal antibodyPaul W Fisher, Michael Brigham-Burke, Sheng-Jiun Wu, et al.
Proteins|September 22, 2011
Antibody modeling assessmentJuan C Almagro, Mary Pat Beavers, Francisco Hernandez-Guzman, et al.
Journal of Molecular Biology|February 2, 2010
De novo selection of high-affinity antibodies from synthetic fab libraries displayed on phage as pIX fusion proteinsLei Shi, John C Wheeler, Raymond W Sweet, et al.
Cancer Chemotherapy and Pharmacology|March 17, 2022
Discovery and pharmacological characterization of cetrelimab (JNJ-63723283), an anti-programmed cell death protein-1 (PD-1) antibody, in human cancer modelsNikki DeAngelis, Catherine Ferrante, Gordon Powers, et al.
Antibodies (Basel, Switzerland)|September 25, 2019
Functional, Biophysical, and Structural Characterization of Human IgG1 and IgG4 Fc Variants with Ablated Immune FunctionalitySusan H Tam, Stephen G McCarthy, Anthony A Armstrong, et al.
Pageof 5

Showing results (31-40 of 48) with videos related to

Sort By:
Pageof 5
Scientific Reports|January 28, 2024
Molecular determinants of ASIC1 modulation by divalent cationsYi Liu, Jichun Ma, Renee L DesJarlais, et al.
Proteins|January 23, 2016
Epitope mapping and structural basis for the recognition of phosphorylated tau by the anti-tau antibody AT8Thomas J Malia, Alexey Teplyakov, Robin Ernst, et al.
Communications Biology|February 10, 2021
Molecular mechanism and structural basis of small-molecule modulation of the gating of acid-sensing ion channel 1Yi Liu, Jichun Ma, Renee L DesJarlais, et al.
Mabs|December 12, 2025
Fine-tuning affinity and spacer design enhances T cell potency in DLL3 and BCMA CAR T cellsNicholas Mazzanti, Ninkka Tamot, Andrea Francese, et al.
Proteins|September 22, 2009
Structure of the EMMPRIN N-terminal domain 1: dimerization via beta-strand swappingJinquan Luo, Alexey Teplyakov, Galina Obmolova, et al.
The Biochemical Journal|December 8, 2004
A novel site contributing to growth-arrest-specific gene 6 binding to its receptors as revealed by a human monoclonal antibodyPaul W Fisher, Michael Brigham-Burke, Sheng-Jiun Wu, et al.
Proteins|September 22, 2011
Antibody modeling assessmentJuan C Almagro, Mary Pat Beavers, Francisco Hernandez-Guzman, et al.
Journal of Molecular Biology|February 2, 2010
De novo selection of high-affinity antibodies from synthetic fab libraries displayed on phage as pIX fusion proteinsLei Shi, John C Wheeler, Raymond W Sweet, et al.
Cancer Chemotherapy and Pharmacology|March 17, 2022
Discovery and pharmacological characterization of cetrelimab (JNJ-63723283), an anti-programmed cell death protein-1 (PD-1) antibody, in human cancer modelsNikki DeAngelis, Catherine Ferrante, Gordon Powers, et al.
Antibodies (Basel, Switzerland)|September 25, 2019
Functional, Biophysical, and Structural Characterization of Human IgG1 and IgG4 Fc Variants with Ablated Immune FunctionalitySusan H Tam, Stephen G McCarthy, Anthony A Armstrong, et al.
Pageof 5